Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Welcome and Introduction to Vi3C

Advertisement

Advertisement




Mar
09
Today In Oncology
Partial Gland Removal May Be an Option for Many Men With Prostate Cancer
How the Cancer Moonshot Is Making a Difference for Patients Here and Across the World
Greater Plant Based Oil Lower Butter Intake Could Improve Risk of Cancer Related Mortality
Breast Cancer Mortality Rates May Have Stopped Declining
SGLT2 Inhibitors Could Help Protect Against Heart Failure in Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo